Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

NCT02907372 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT02907372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02907372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer
Lead sponsor
Centre Francois Baclesse
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2016
Completion date
December 31, 2022
Enrollment
163 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer (crpca)